Skip to content

Application of Stratified Multicomponent Exercise in Mobility Limitation Among Elderly Patients with Chronic Heart Failure

Application of Stratified Multicomponent Exercise in Mobility Limitation Among Elderly Patients with Chronic Heart Failure

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600123135
Enrollment
Unknown
Registered
2026-04-22
Start date
2026-04-30
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Heart Failure

Interventions

Intervention group:**I. For Elderly Patients with Chronic Heart Failure and an SPPB Score of 0–3, a 12-Week Progressive, Stratified Exercise Intervention is Implemented. The intervention is divided in

Sponsors

The First Affiliated Hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Age >= 60 years; 2. Clinically diagnosed with chronic heart failure, in accordance with the diagnostic criteria specified in the 2023 European Society of Cardiology (ESC) Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure, with cardiac function classified as NYHA Class I–III; 3. Voluntarily participated in this study and signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Complicated with severe cardiovascular diseases or presenting with the following conditions: early stage of acute coronary syndrome, acute arrhythmia, high-grade atrioventricular block, acute myocarditis, infective endocarditis, new-onset atrial fibrillation, acute heart failure, severe aortic stenosis, obstructive hypertrophic cardiomyopathy, intracardiac thrombus, unstable angina or myocardial infarction within 3 months, cardiac arrest within 6 months, peripartum cardiomyopathy within 6 months, severe chronic obstructive pulmonary disease, poorly controlled blood pressure (systolic blood pressure >= 180 mm Hg or diastolic blood pressure >= 100 mm Hg), or resting heart rate > 120 beats per minute; 2. Complicated with metabolic diseases such as acute thyroiditis, hypokalemia, hyperkalemia, etc.; 3. Implanted with devices such as implantable cardioverter-defibrillator (ICD) or cardiac resynchronization therapy (CRT); 4. Others: valvular heart disease requiring surgery, or patients scheduled for heart transplantation.

Design outcomes

Primary

MeasureTime frame
short physical performance battery, SPPB;

Secondary

MeasureTime frame
6-minute walk distance,6MWD;Minnesota Living with Heart Failure Questionnaire,MLHFQ);Pittsburgh Sleep Quality Index, PSQI;Montreal Cognitive Assessment, MoCA;

Countries

China

Contacts

Public ContactShi Tieying

The First Affiliated Hospital of Dalian Medical University

Sty11177@163.com+86 180 9887 1912

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 1, 2026